ArticleMolecular oncology2026
Paclitaxel induces NM2-dependent cellular contraction through GEF-H1 dissociation from microtubules and RhoA/ROCK activation in cancer cells.
Article in Molecular oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
In this study, we have investigated the crosstalk between microtubule dynamics and actomyosin contractility in cancer cells treated with taxanes, which are chemotherapeutic agents used to treat solid tumors. We found that paclitaxel (PTXL) induced cell contraction through a mechanism that involved the rapid dissociation of GEF-H1 from microtubules, and the phosphorylation and acute activation of NM2 in a RhoA-dependent manner. Mutation of a major α-tubulin regulatory site (K40R) markedly slowed and reduced the efficiency of PTXL-induced GEF-H1 dissociation, indicating that this site is required for the full, rapid release of GEF-H1 from the microtubule lattice. Inhibitors of tubulin deacetylase HDAC6 promoted a slow release of GEF-H1 from microtubules and a lagged accumulation of phosphorylated NM2. Unexpectedly, depletion of tubulin acetyltransferase αTAT1 also induced NM2 phosphorylation, indicating that microtubule acetylation is involved in the maintenance of contractile homeostasis. Together, these results indicate that PTXL induces rapid cellular contraction dependent on the GEF-H1-RhoA-ROCK axis, in which K40 of α-tubulin gates the efficiency of GEF-H1 dissociation from microtubules, whereas homeostatic, αTAT1-dependent microtubule acetylation maintains appropriate levels of cellular contractility through long-term control of NM2 phosphorylation and actomyosin organization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.